Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing results three months ago. GLP-1 agonist Wegovy ...

Share on Pinterest Weight loss drugs like Ozempic and Wegovy have been liked with strong relief from osteoarthritis knee pain. Nazar Rybak/Getty Images A new study suggests semaglutide use may ...

Weight loss jabs could be 'game-changers' in tackling common cancer, claim doctors Credit: Getty Professors Tim Spector and Sarah Berry of King’s College London are now heading a five-year £ ...

Semaglutide is sold by Novo Nordisk as Ozempic for treatment of type 2 diabetes and as Wegovy for weight management. It belongs to a class of drugs known as GLP-1 receptor agonists. Researchers ...

Other side effects include 7,228 reports of nausea, vomiting, and diarrhoea linked to the use of weight loss jabs such as Wegovy and Ozempic. Out of the patients who reported the above side ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

Indian drugmakers are preparing for the launch of copycat weight-loss drugs as the world moves towards the patent expiry of Novo Nordisk’s blockbuster brands Ozempic and Wegovy. The Danish firm’s ...

To sign up for Becker's Orthopedic Review E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may need to whitelist our new ...